Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

PROSHARES TRUST (ZBIO) Non Operating Income: 2023-2024

Historic Non Operating Income for Zenas BioPharma (ZBIO) over the last 2 years, with Dec 2024 value amounting to $8.2 million.

  • Zenas BioPharma's Non Operating Income fell 54.54% to $1.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $11.0 million, marking a year-over-year increase of 100.02%. This contributed to the annual value of $8.2 million for FY2024, which is 1210.10% up from last year.
  • Zenas BioPharma's Non Operating Income amounted to $8.2 million in FY2024, which was up 1,210.10% from $624,000 recorded in FY2023.
  • In the past 5 years, Zenas BioPharma's Non Operating Income ranged from a high of $8.2 million in FY2024 and a low of $624,000 during FY2023.
  • For the 2-year period, Zenas BioPharma's Non Operating Income averaged around $4.4 million, with its median value being $4.4 million (2023).
  • Data for Zenas BioPharma's Non Operating Income shows a peak YoY soared of 1,210.10% (in 2024) over the last 5 years.
  • Zenas BioPharma's Non Operating Income (Yearly) stood at $624,000 in 2023, then surged by 1,210.10% to $8.2 million in 2024.